Marshall S. Stanton, SVP, Clinical & MD Affair at ARTIVION, INC. (AORT), sold 94,752 shares at $44.91 ($4.3M) on 2025-11-21, disclosed to the SEC on 2025-11-24.
Open-market sale of $4.3M AORT by SVP, Clinical & MD Affair. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.91 | 18,705 | $840K | 19.7% |
| 2 | $44.91 | 18,705 | $840K | 19.7% |
| 3 | $44.92 | 14,586 | $655K | 15.4% |
| 4 | $44.92 | 14,586 | $655K | 15.4% |
| 5 | $45.35 | 5,715 | $259K | 6.1% |
| 6 | $45.35 | 5,715 |
| $259K |
| 6.1% |
| 7 | $45.35 | 8,370 | $380K | 8.9% |
| 8 | $45.35 | 8,370 | $380K | 8.9% |
| Total | $45.04 avg | 94,752 | $4.3M | 100% |
| Filing → |
| AORT | SELL | 2026-02-25 | $136K | — | Filing → |
| AORT | SELL | 2025-11-24 | $1.3M | — | Filing → |
| AORT | SELL | 2025-11-14 | $458K | — | Filing → |